SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nureca informs about outcome of board meeting

14 Feb 2022 Evaluate

Nureca has informed that the Board of Directors of the Company at its meeting held on February 12, 2022, has approved the un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021. Copies of un-audited Financial Results along with Limited Review Reports from the Company's Statutory Auditors are enclosed, declared an Interim Dividend of Rs 3.0 per Equity Share of Rs 10 each at the rate of 30%. The dividend shall be paid/dispatched to the Shareholders on or before 30 days from the date of its declaration, approved the appointment of Sushil Kumar Bhardwaj (DIN 09468448) as an Additional Director & Whole-time Director of the Company designated as Director - Compliance for a period of three years with effect from February 12, 2022, and approved the change of nomenclature of Registered Office Address of the Company from ‘Gala No. 101, 1st Floor, Udyog Bhavan Sonawala Lane, Goregaon East, Mumbai, Maharashtra -400063’ to ‘Office No. 101, 1st Floor, Udyog Bhavan Sonawala Lane, Goregaon East, Mumbai, Maharashtra-400063’ with immediate effect from February 12, 2022. Presentation on financial results for the third quarter and nine months ended December 31, 2021 is also enclosed. The Board Meeting commenced at 7:00 pm and concluded at 9.35 pm.

The above information is a part of company’s filings submitted to BSE.

Nureca Ltd. Share Price

258.70 -5.10 (-1.93%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 533.70
Poly Medicure 1455.50
Laxmi Denta 193.25
Nureca Ltd. 258.70
Hemant Surgical Inds 308.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×